Semnur Pharmaceuticals Valuation Multiples

Semnur Pharmaceuticals Overview

About Semnur Pharmaceuticals

Semnur Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its product candidate, SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SP-102 or SEMDEXATM).

Founded

2013

HQ

Employees

N/A

Website

semnurpharma.com

Sectors

BiopharmaceuticalsE-commerce - Inventory-BasedBioTech

Financials (FY)

Revenue: —

EBITDA: ($160M)

EV

$2B

Valuation Multiples

Multiples.vc

Start free trial

Semnur Pharmaceuticals Financials

Semnur Pharmaceuticals reported last fiscal year revenue of — and negative EBITDA of ($160M).

In the same fiscal year, Semnur Pharmaceuticals generated ($160M) in EBITDA losses and had net loss of ($160M).

Semnur Pharmaceuticals P&L

In the most recent fiscal year, Semnur Pharmaceuticals reported revenue of — and EBITDA of ($160M).

Semnur Pharmaceuticals expects next 12-month revenue of XXX and NTM EBITDA of XXX

Semnur Pharmaceuticals Stock Performance

Semnur Pharmaceuticals has current market cap of $2B, and enterprise value of $2B.

Semnur Pharmaceuticals' stock price is $8.00.

Semnur Pharmaceuticals Valuation Multiples

Semnur Pharmaceuticals trades at (11.5x) EV/EBITDA.

Semnur Pharmaceuticals Financial Valuation Multiples

As of March 29, 2026, Semnur Pharmaceuticals has market cap of $2B and EV of $2B.

Equity research analysts estimate Semnur Pharmaceuticals' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Semnur Pharmaceuticals has a P/E ratio of (11.5x).

Semnur Pharmaceuticals Margins & Growth Rates

Semnur Pharmaceuticals' revenue in the last fiscal year grew by —.

Semnur Pharmaceuticals Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Semnur Pharmaceuticals M&A Activity

Semnur Pharmaceuticals acquired XXX companies to date.

Last acquisition by Semnur Pharmaceuticals was on XXXXXXXX, XXXXX. Semnur Pharmaceuticals acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Semnur Pharmaceuticals Investment Activity

Semnur Pharmaceuticals invested in XXX companies to date.

Semnur Pharmaceuticals made its latest investment on XXXXXXXX, XXXXX. Semnur Pharmaceuticals invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).